benzonatate
- Product NDC
- 42708-107
- 11-digit product format
- 427080107
- Labeler code
- 42708
- Product ID
- 42708-107_bc06aac1-9303-7cd3-e053-2995a90aa148
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- benzonatate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- QPharma Inc
- Application
- ANDA040749
- Marketing category
- ANDA
- Marketing start
- 2017-03-22
- Marketing end
- 0000-00-00
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42708-107-30 | 42708010730 | 30 CAPSULE in 1 BOTTLE (42708-107-30) | 30 capsule | 2017-03-22 | 0000-00-00 | Yes | No | Current |